PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Anacyclus pyrethrum extract (100mg/kg) protected male rats against cadmium reproductive toxicity and improved sperm functions [PMID:39604977]
Aqueous and methanolic extracts of the root demonstrated anticonvulsive and neuroprotective effects in mice [PMID:31710948]
Ethanol extracts of the root (EEAP) showed potential effectiveness in treating a mouse model of PD-MCI [PMID:40253741]
Aqueous extract of A. pyrethrum was investigated for its potential to mitigate adverse effects of Fentanyl withdrawal in a mouse model [PMID:38927359]
Ethanol extract of the root reduced cough frequency, inflammatory effects, and oxidative stress in a rat model [PMID:37910337]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 30000694 (2006) — Botanical insecticides, deterrents, and repellents in modern agriculture and an increasingly regulated world. · Annual review of entomology
- 2.PMID: 38692343 (2024) — Alkaloid constituents from Anacyclus pyrethrum. · Phytochemistry
- 3.PMID: 19445766 (2009) — Head lice. · BMJ clinical evidence
- 4.PMID: 40253741 (2025) — Integrated network pharmacology, metabolomics, and microbiome studies to reveal the therapeutic effects of Anacyclus pyrethrum in PD-MCI mice. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 5.PMID: 39216630 (2025) — Alkaloids from Anacyclus pyrethrum.